---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-023525"
form_type: "8-K"
ticker: "PPCB"
cik: "0001517681"
company_name: "Propanc Biopharma, Inc."
filed_at: "2024-06-12T23:59:59+00:00"
generated_at: "2026-06-01T04:49:39.471015+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Propanc Biopharma enters loans totaling $120K AUD at 12% interest

## Summary
- First loan of $20,000 AUD on June 3, 2024, at 12% annual interest, maturing June 3, 2025.
- Second loan of $100,000 AUD on June 5, 2024, at 12% annual interest, maturing June 5, 2025.
- Proceeds used for general working capital; prepayment allowed without penalty.
- Loans issued under Section 4(a)(2) private placement exemption.

## SEC filing metadata
- accession: 0001493152-24-023525
- form_type: 8-K
- ticker: PPCB
- cik: 0001517681
- company_name: Propanc Biopharma, Inc.
- filed_at: 2024-06-12T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1517681/000149315224023525/0001493152-24-023525-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1517681/000149315224023525/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-023525
- JSON: https://secwatch.observer/filing/0001493152-24-023525.json
- Plain text: https://secwatch.observer/filing/0001493152-24-023525.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.